Both in Biotechnology
Caribou Biosciences vs Kalaris Therapeutics
Over the past year CRBU returned −81.6% and KLRS returned −57.9%; their daily moves had a correlation of 0.15.
CRBU −81.6% KLRS −57.9%Growth of $1, one year, split-adjusted
| Metric | CRBU | KLRS |
|---|---|---|
| Price | $0.4473 | $2.10 |
| Market cap | $48.0M | $50.0M |
| Today | −2.63% | +2.44% |
| 1 month | −60.6% | −21.1% |
| 6 months | −77.1% | −58.5% |
| Year to date | −71.9% | −75.1% |
| 1 year | −81.6% | −57.9% |
| Revenue growth (YoY) | −43.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −1619.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.8× | — |
| Net cash | $112.3M | $93.5M |
| Dividend yield | — | — |
| Volatility (60d) | 146.2% | 56.4% |
| Short % of float | 13.5% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).